How many insider declarations has venBio Global Strategic Fund IV, L.P. filed?

venBio Global Strategic Fund IV, L.P. has filed 4 public insider declarations with SEC (Form 4).

What is venBio Global Strategic Fund IV, L.P.'s role?

venBio Global Strategic Fund IV, L.P.'s reported role is not specified by the regulator across the filings.

Which companies does venBio Global Strategic Fund IV, L.P. report trades for?

venBio Global Strategic Fund IV, L.P. reports trades for Attovia Therapeutics, Inc..

What is venBio Global Strategic Fund IV, L.P.'s declared buy vs sell volume?

Across the available history, declared buys total 5.6M€ and disposals 0.

← Executives ★ Sign in to follow

VG

venBio Global Strategic Fund IV, L.P.

·SEC (Form 4)

Attovia Therapeutics, Inc.

0

申报总数

0

公司

€562万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by venBio Global Strategic Fund IV, L.P.. Insider active across 1 company, notably Attovia Therapeutics, Inc.. Aggregated, 4 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €5.6m. Activity tracked since 6 August 2026. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to venBio Global Strategic Fund IV, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Attovia Therapeutics, Inc. (US)

申报4 总计

●

venBio Global Strategic Fund IV, L.P.

10% Owner高管2026年8月6日Attovia Therapeutics, Inc.

0SEC ↗

2,311,870 股Common StockSEC:0000905148-26-003548:0

●

venBio Global Strategic Fund IV, L.P.

10% Owner高管2026年8月6日Attovia Therapeutics, Inc.

0SEC ↗

821,998 股Common StockSEC:0000905148-26-003548:1

●

venBio Global Strategic Fund IV, L.P.

10% Owner高管2026年8月6日Attovia Therapeutics, Inc.

0SEC ↗

665,147 股Common StockSEC:0000905148-26-003548:2

▲

venBio Global Strategic Fund IV, L.P.

10% Owner高管2026年8月6日Attovia Therapeutics, Inc.

US$650万0SEC ↗

382,352 股@ US$17.00Common StockSEC:0000905148-26-003548:3

标准退出：2026年11月4日 (T+90)

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

VG

venBio Global Strategic Fund IV, L.P.

·SEC (Form 4)

Attovia Therapeutics, Inc.

0

申报总数

0

公司

€562万

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the full record of transactions filed by venBio Global Strategic Fund IV, L.P.. Insider active across 1 company, notably Attovia Therapeutics, Inc.. Aggregated, 4 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €5.6m. Activity tracked since 6 August 2026. The latest transaction was disclosed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.